The increasing demand for precise immunological investigation and therapeutic development has spurred significant improvements in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using various expression systems, including prokaryotic hosts, higher cell cultures,